Analysis 1: (from outside to inside)
Beginning in 2000, P&G began to reduce its internal R&D cost investment, shifting from focusing on internal R&D to focusing on open R&D processes. In P&G's business model, three platforms have been established: technology entrepreneurs, Internet platforms and retired experts, which have greatly promoted internal R&D efficiency. First, technology entrepreneurs
are scientists from within P&G. They continue to establish good relationships with external universities and companies to find external research solutions to solve P&G's internal problems. Second, through the Internet platform, establish connections with problem experts around the world, expose their own research problems, and reward those who help P&G come up with solutions.
Third, solicit knowledge from retirement experts through YourEncore.com.
Analysis 2: (from inside to outside)
In order to make drugs more accessible in poor countries, GlaxoSmithKline opens up intellectual property rights related to difficult and complicated diseases to the outside world. Establish a patent pool to collect the intellectual property rights of different patent holders to prevent R&D progress from being hindered by a certain patent holder.